News

YD Bio Limited Secures Nasdaq Listing and Business Milestone

YD Bio Limited Secures Nasdaq Listing and Business Milestone

YD Bio Limited Completes Business Combination

YD Bio Limited, a leading biotechnology innovator, has announced the successful completion of its business combination, marking a pivotal moment in the company’s journey. This strategic move aims to accelerate the company’s growth and innovation within the healthcare market. With the completion of this transaction, YD Bio is well-positioned to evolve as a significant player in the biotechnology landscape.

Upcoming Trading on Nasdaq

The company’s ordinary shares and warrants will begin trading on the Nasdaq Global Market under the ticker symbols "YDES" and "YDESW," starting on August 29, 2025. This transition to public markets is expected to facilitate greater operational resources and enhance its capabilities in cancer detection technologies and ophthalmologic treatments.

Significant Financial Milestones

YD Bio Limited has also successfully closed a PIPE (Private Investment in Public Equity) offering concurrently with the business combination. The funding from these activities, alongside cash released to YD Bio from the previous trust established for former Breeze shareholders, is projected to provide over $11.5 million. This capital will be instrumental in supporting the company's ongoing projects and clinical developments.

Strategic Outlook

The combination of YD Bio with Breeze Holdings Acquisition Corp. is a crucial step in pursuing the company’s vision of advancing healthcare solutions. As a newly public entity, YD Bio aims to enhance its role in developing innovative pharmaceuticals and transformative diagnostics that address critical health challenges.

Innovative Technology and Research Focus

At the core of YD Bio Limited's mission is its commitment to cutting-edge research and development. The company is known for its partnerships with biopharmaceutical firms to translate advanced technologies into products that can ideally improve patient outcomes. Notably, the company focuses on:

  • Blood-Based Cancer Detection: Utilizing proprietary DNA methylation technology, YD Bio is developing tests for cancers, including an early-detection screening for pancreatic cancer and a monitoring test for breast cancer recurrence.
  • Stem Cell and Exosome Therapies: YD Bio is innovating in ocular therapies through partnerships aimed at treating conditions like dry eye syndrome and glaucoma using stem cell and exosome technologies.
  • Clinical Trial Support: The company offers essential services for clinical trials, supplying investigational drugs and materials, reinforcing their partnerships with pharmaceutical companies.

Leadership and Vision

Dr. Ethan Shen, the Chairman and CEO, emphasizes that this moment not only celebrates the company’s past achievements but also heralds a new chapter of rapid growth and innovation. He acknowledges the support from patients and investors that has enabled YD Bio’s transition into a publicly traded entity. Dr. Shen’s extensive expertise in biomedical fields positions YD Bio to make substantial advancements in oncology and regenerative medicine.

Company Background and Future Goals

YD Bio Limited is dedicated to advancing healthcare solutions, standing at the forefront of biotechnology that seeks to address high unmet medical needs in cancer care and ocular health. The company’s commitment to rigorous scientific research is evident as they work diligently on numerous clinical trials, striving for innovation and excellence.

This listing on Nasdaq is just the beginning for YD Bio. The company is excited to continue its mission to redefine standards in healthcare and improve patient lives with its innovative solutions.

Frequently Asked Questions

What is the ticker symbol for YD Bio Limited on Nasdaq?

YD Bio Limited trades under the ticker symbols 'YDES' for ordinary shares and 'YDESW' for warrants on Nasdaq.

What technologies is YD Bio Limited focusing on?

YD Bio is focusing on blood-based cancer detection, stem cell therapies for ocular conditions, and providing clinical trial support services.

How much funding has YD Bio Limited secured recently?

YD Bio has secured over $11.5 million through the PIPE offering and trust cash from the business combination.

Who leads YD Bio Limited?

Dr. Ethan Shen serves as the Chairman and CEO of YD Bio Limited, bringing over 30 years of experience in the biomedical sector.

What is the primary mission of YD Bio Limited?

YD Bio’s mission is to advance innovative healthcare solutions that improve patient outcomes and address critical health challenges through scientific research and technological innovation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

IDX Expands, Enhances Team Amid 56% H1 Growth

Updated Category News Views 1

IDX's Aggressive Global Expansion Here's a tip from a trader who’s seen cycles rise and fall: watch the movers who're playing the long game, putting down roots worldwide while making headway in the data game. IDX has clearly mapped out this trajectory as evidenced by its recent grab in the global strategic communications ring. IDX's bustling around like a squirrel...

Continue Reading
Strategic Hire: Whisenhunt Joins FlexScreen & RiteScreen

Updated Category News Views 1

Shaking Up the Window Screens Biz If you've been grinding in the window and door game, you know it's not an industry with a lot of buzz, but here comes a shot of caffeine. FlexScreen and RiteScreen just snagged David Whisenhunt to rev up their sales machine. Who's David Whisenhunt? Well, he's no rookie. With over two decades deep in the fenestration field, Whisenhunt...

Continue Reading
Intellectia.AI Transforming Trading with AI Upgrades

Updated Category News Views 1

Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...

Continue Reading
BrightPlan's AI-Powered Growth: Series C Fuel

Updated Category News Views 5

Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...

Continue Reading
Celebree Elevates Early Ed with New Certification Push

Updated Category News Views 3

A New Standard in Early Childhood Education In the cutthroat world of childcare and early education, just meeting the state standards ain't cutting it anymore. Celebree School, known for its infant, toddler, and preschool programs, is shaking things up with its 'Celebree Certified' initiative, setting a brand-new benchmark for teacher readiness that's far beyond the usual...

Continue Reading
Leidos' Autonomous Vessels Chart Bold Naval Waters

Updated Category News Views 1

Leidos' Autonomous Leap with the U.S. Navy Well, today it's all about Leidos, an outfit that's been showing its grit in the world of maritime autonomy. Their systems aren't just tinkering around anymore—they're slicing through the waves at RIMPAC, the Rim of the Pacific, and running alongside the USS Theodore Roosevelt Carrier Strike Group. That's big news in anyone's...

Continue Reading
Illinois' Legal Tangle: Feds Under Fire?

Updated Category News Views 2

What a tangled web Illinois lawmakers have woven this time. They've gone and cooked up a pair of laws with a real knack for attracting attention—specifically from the folks over at the National Police Association (NPA). These aren’t your run-of-the-mill rules; they feel more like a blueprint for putting federal officers through the legal wringer and turning courtroom...

Continue Reading
How Timekettle Is Bridging Language Gaps at IFA 2026

Updated Category News Views 4

Pioneering AI Innovations in Language Translation Timekettle is making some serious waves at IFA 2026, throwing its hat in the ring with innovations that redefine multilingual interaction. From sleek translation earbuds to full-blown meeting hubs, each gadget screams one thing loud and clear—communication sans language barriers. Centered in the tech extravaganza of...

Continue Reading
Austin PostalAnnex Changes Hands After 19 Years

Updated Category News Views 3

A Seamless Transition in Austin's PostalAnnex Legacy You know when a business digs its roots deep, becoming more than just a place but a part of the community fabric? That's what’s playing out at the PostalAnnex on W Parmer Lane, Austin. After nearly two decades, this battered yet steadfast hub of office and shipping services is swapping hands, all in the name of...

Continue Reading
Stoke Space Raises $1B; XTEND AI Hits NYSE

Updated Category News Views 2

A Billion-Dollar Boost for Stoke Space Ever catch wind of a company hauling in a cool billion and shrug it off? Me neither. Stoke Space Technologies just locked down $1 billion in Series E funding. This ain't some pocket change—the kind of dough you need when you're eyeing stars and plotting orbital voyages. They're gearing up for a 2027 mission with their Nova...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Action Launched Against Charter Communications, Inc.

Updated Category News Views 188

Overview of the Class Action Against Charter Communications Charter Communications, Inc. (NASDAQ: CHTR) is facing a class action securities lawsuit initiated by Levi & Korsinsky, LLP. This legal action aims to represent investors adversely affected by alleged fraudulent practices related to the company's operations. Investors are encouraged to engage with Levi & Korsinsky...

Continue Reading
Consumers Energy's Innovative Grid Solutions Reduce Outage Time

Updated Category News Views 190

Consumers Energy’s Commitment to Reliability Consumers Energy has made significant strides in enhancing the reliability of its electric grid, resulting in exciting improvements for nearly 2 million households and businesses. In 2024, customers celebrated an average reduction of 21 minutes in power outage durations compared to the previous year. Additionally, over 93% of...

Continue Reading
Comcast Innovates Edge Computing for a Superior Streaming Experience

Updated Category News Views 198

Comcast Embraces Edge Computing for Streaming Growth Comcast is making notable advancements in internet services by adopting edge computing technology. This innovation aims to bring greater computing power closer to users, which in turn enhances their internet experiences, particularly for streaming and gaming. Furthermore, this initiative is geared towards establishing a...

Continue Reading
Navigating the QUBT Earnings Announcement with Confidence

Updated Category News Views 97

Anticipating Quantum Computing’s Earnings Report Quantum Computing Inc (NASDAQ: QUBT) is poised to reveal its next quarterly earnings report, and investors are keen to uncover the potential insights it may bring. Understanding the financial landscape can empower investors to make informed decisions, especially before such significant announcements. Earnings Projections...

Continue Reading
Jupiter Power and Consumers Energy Launch Michigan's New Battery Project

Updated Category News Views 269

Jupiter Power and Consumers Energy Launch a Revolutionary Battery Storage Project Recently, Jupiter Power LLC and Consumers Energy celebrated a significant milestone in energy innovation by marking the launch of the Tibbits Energy Storage Facility. This facility is Michigan's first operational utility-scale battery storage system, designed specifically to enhance energy...

Continue Reading